Pharmaceutical Inspection: Topics of Special Interest Flashcards

1
Q

What is a remote inspection vs an on-site inspection?

A
  1. On-site inspection
    - Inspectors are physically present at manufacturing site to assess company’s compliance with GMP (or GXP) standards and other regulatory requirements.
  2. Remote inspection (aka off-site, virtual, distant or e-inspection)
    - Mimics on-site inspection, enabled by e-technology.
    - Strives to mimic on-site inspection in terms of format, time-frame and overall rigot
  3. Desktop inspection:
    - A form of remote inspection based on review of documentary evidence provided by the company; largely a “paper-based” remote inspection.

Hybrid inspection is a combination of all three.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the arrangements for remote inspections?

A
  • Agree on Virtual Conference (Inspection) Platform
  • Assure Strong Internet/ Wifi Connectivity Audio Visual Resolution of Webcam System
  • Know the Parties Involved & Their Roles
  • Agree on Inspection Time and Duration , and Time Zones for Remote Overseas Inspections
  • Make Arrangements relating to Confidentiality, Security & Access to File Sharing Platforms
  • Agree on Safety Arrangements
  • Deal with Document System (Likely to be Hybrid), comprising Paper and Electronic Records
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the challenges of remote inspections?

A
  • Existing e Technology Limitations due to Unstable Internet Connectivity Poor AV Resolution
  • Limited Resources at Manufacturing Sites (due to Split Teams ) during COVID- 19 Pandemic
  • Overall Slower Response Time to complete a remote inspection
  • Lack of body language can distort discussions
  • Difficult to inspect utilities and manufacturing operations
  • As technology advances & use of digital tools become norm, Remote Inspections
    may not be so challenging.
  • As of now, Remote Inspections tend to be largely Desktop Inspections; however, post Covid-19 may see more Hybrid Inspection and Use of Mutual Reliance Program.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the benefits of PIC/S membership?

A
  • Reduced Duplication of GMP Inspections

- Increased Opportunity for Collaborations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the core framework used for the ASEAN Sectoral MRA, on GMP Inspection, and what does the MRA cover?

A

Framework: PIC/S
Covers:
- Pharmaceutical products in finished dosage forms
- Both prescription medicines and OTC products
- Does not cover biopharmaceutical products and APIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the benefits of ASEAN MRA on GMP Inspection?

A
  • Avoids duplication of Pharmaceutical Inspections within ASEAN
  • Saves Time , Resources and Costs for Manufacturers & Regulators
  • Facilitates Trade in Medicinal Products across ASEAN
  • Quicker Access of Medicinal Products by ASEAN Patients
  • Also Harmonizes ASEAN Inspection System to that of PIC/S
  • Increases Attractiveness of ASEAN to Regulators & Investors from Asia & Rest of the World!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Negotiations of MRA

A
  • MRA can take a relatively long time to negotiate/conclude.
  • Often, MRAs are negotiated under larger platform of Free Trade Agreements (FTAs).
  • MRA negotiations involve Regulators , Lawyers/AGC, Trade & Industry Representatives etc.
  • Considerations are given to Pharmaceutical Import/Export
    Volumes, Political, Legal, Social & other Trade/Services
  • Mutual reliance approach (MRA) could be a good first step forward
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does the framework of PIC/S GMP Inspection include?

A
  • Having a MRA on GMP Inspection in place; or
    -Recognition of GMP Compliance Status of a facility located within territory of a
    PIC/S Participating Authority ; or
    -Recognition of inspection outcome by a Hosting Inspectorate
    which has been assessed under a robust framework, e.g.
    PIC/S JAP or JRP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

WHO Good Reliance Practices

A
  • Covers Reliance Activities in Regulation of Medical Products
  • Spans the entire product life cycle and includes GMP inspections
  • Intended for all national regulatory authorities regardless of their maturity levels and resources.
  • WHO recommends various approaches to reliance.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is reliance (according to the WHO Good Reliance Practices)

A
  • An act whereby an NRA takes into account an assessment performed
    by another NRA (or trusted institution) in reaching its own decision.
  • The relying NRA remains independent, responsible & accountable for
    decisions taken, even as it relies on the assessment of another NRA.
  • Reliance does not represent a less stringent form of regulation or an
    outsourcing of regulatory mandate
  • On the contrary, mutual reliance is the hallmark of a modern and
    efficient regulatory authority and smart regulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The use of ______ and ____ can be a viable alternative to on-site inspections.

A

remote inspections, reliance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Benefits of remote inspections and reliance

A
  • Remote Inspections Have Enabled Business Continuity During Covid 19; and
  • Post COVID 19, They Can Decrease Travel Times for Domestic & Overseas Inspections
  • Accord Flexibilities to Inspectors & Inspectees regarding Time Frames & Inspection Pace
    -During current pandemic, remote inspections reliance are the only 2 options
    available for Overseas Manufacturers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the different GMP assessment approaches that most national laws allow for?

A

on-site, remote or hybrid inspections, or use of reliance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the advantages of nanomedicines?

A
  • Effective in Targeting Difficult To Reach ( Tumour ) Sites
  • Improved Solubility, Bioavailability & Reduced Side Effects
  • Achievement of Same Therapeutic Effect with Smaller Doses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why do nanomedicines have special properties?

A

due to their unique size, shape and surface chemistry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Limitations of conventional product testing

A
  • can only test on a “representative” sample size
  • can test only if the analyte and test method is known
  • can test only if the test method if specific, accurate and reliable
  • conventional QC tests are also destructive, poor quality units are not picked up due to statistical units
  • defects picked up only at the end of manufacturing process, and cannot be rectified/reworked.
  • QC tests are not conducted/released in real time, resulting in huge expenses incurred for storage space.
17
Q

Advantages and benefits of QbD/PAT

A
  • Non destructive (unlike conventional QC testing)
  • Deeper process understanding, better control & higher QA
    (due to ability to scan/image entire batch of material/product)
  • Real time release of products (soon after manufacture)
  • Cost Savings for the Industry
18
Q

What are the challenges to QbD/PAT implementation?

A
  • Limited understanding of QbD/PAT
  • High financial investment in PAT
    » Initial capital outlay, technology maintenance and training costs may be high
    » Long term savings from reduced QC tests, increased yield and immediate release
  • Old Habits Die Hard
    » Industry accustomed to not reviewing a validated process (based on QbT)
  • Regulators are not ready QbD/PAT submissions
    » Regulators used to old paradigm of QbT
19
Q

Advantages of continuous manufacturing

A
  • Higher QA through in-line or at-line testing using non-destructive PAT/Other technologies
  • Real time release of finished product – saving of warehouse space
  • Shorter total batch processing time – day(s)  cost savings and increased efficiency
  • Integrated processes (fewer steps)
    » Minimal manual handling – reduced contamination
  • Smaller equipment and facilities
    » More flexible operation
    » Reduced inventory
    » Lower capital cost
  • On-line monitoring & QC via PAT?Other Technologies
    » Higher level of QA
    » More consistent quality
    » Real time release (RTR)
20
Q

How to assure API Supply Chain Integrity?

A
  • Many players in supply chain from manufacture of API, to production
    of finished product, to distribution of finished products to point of use.
  • Increased number of players in API/product supply chain
    » Many potential points for interference of API/product
    » Falsified Medicines
  • GMP/GDP compliance and vigilance can help:
    » Assure Quality of API/Finished Products
    » Deter Manipulation by Unscrupulous Supply Chain Players
    » Detect Adulterated Products, Counterfeits & Falsified Medicines